Transforming Hypertrophic Cardiomyopathy Care
The Associate Director, Quality provides clinical and nonclinical quality oversight for assigned studies, vendors, and workstreams, serving as a senior quality advisor across Braveheart Bio's clinical programs. This role involves developing quality strategies, ensuring GCP compliance, and leading inspection readiness activities for late-stage clinical programs. The position requires close collaboration with clinical development teams to embed quality expectations throughout the study lifecycle.
Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Transforming Hypertrophic Cardiomyopathy Care.